Search Results

There are 3683 results for: content related to: Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch

  1. Dose-Dependent Response to Phenylpropanolamine: Inhibition of Orthostasis

    The Journal of Clinical Pharmacology

    Volume 31, Issue 7, July 1991, Pages: 624–635, Dr. C. Raymond Lake, David B. Rosenberg, Dr. Sheryle Gallant, Gary Zaloga and Bart Chernow

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1991.tb03748.x

  2. Noradrenergic Agents

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 233–254, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch13

  3. Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine

    Clinical Pharmacology & Therapeutics

    Volume 55, Issue 1, January 1994, Pages: 35–43, Creina S Stockley, Lindon M H Wing, Anne L Tonkin and John O Miners

    Version of Record online : 16 JAN 1994, DOI: 10.1038/clpt.1994.7

  4. Enamine prodrugs

    Journal of Pharmaceutical Sciences

    Volume 60, Issue 12, December 1971, Pages: 1810–1812, H. C. Caldwell, H. J. Adams, R. G. Jones, W. A. Mann, L. W. Dittert, C. W. Chong and J. V. Swintosky

    Version of Record online : 21 SEP 2006, DOI: 10.1002/jps.2600601207

  5. Adrenergic drugs for urinary incontinence in adults

    Intervention Review

    The Cochrane Library

    Ammar Alhasso, Cathryn MA Glazener, Robert Pickard and James MO N'Dow

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD001842.pub2

  6. The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation

    Clinical Pharmacology & Therapeutics

    Volume 47, Issue 6, June 1990, Pages: 747–754, Robert C Klesges, Lisa M Klesges, Andrew W Meyers, Mary L Klem and Terry Isbell

    Version of Record online : 3 JUN 1990, DOI: 10.1038/clpt.1990.103

  7. A pharmacodynamic interaction between caffeine and phenylpropanolamine

    Clinical Pharmacology & Therapeutics

    Volume 50, Issue 4, October 1991, Pages: 363–371, Nancy J Brown, Diane Ryder and Robert A Branch

    Version of Record online : 17 OCT 1991, DOI: 10.1038/clpt.1991.152

  8. Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs

    Journal of Pharmaceutical Sciences

    Volume 70, Issue 4, April 1981, Pages: 379–384, Y. Raghunathan, L. Amsel, O. Hinsvark and W. Bryant

    Version of Record online : 22 SEP 2006, DOI: 10.1002/jps.2600700409

  9. Stability of phenylpropanolamine hydrochloride in liquid formulations containing sugars

    Journal of Pharmaceutical Sciences

    Volume 71, Issue 1, January 1982, Pages: 116–118, R. H. Barry, M. Weiss, J. B. Johnson and E. Deritter

    Version of Record online : 21 SEP 2006, DOI: 10.1002/jps.2600710129

  10. Phenylpropanolamine increases plasma caffeine levels

    Clinical Pharmacology & Therapeutics

    Volume 47, Issue 6, June 1990, Pages: 675–685, C Raymond Lake, David B Rosenberg, Sheryle Gallant, Gary Zaloga and Bart Chernow

    Version of Record online : 3 JUN 1990, DOI: 10.1038/clpt.1990.93

  11. Selective determination of phenylpropanolamine hydrochloride in pharmaceutical dosage forms by reaction with ninhydrin

    Journal of Pharmaceutical Sciences

    Volume 63, Issue 2, February 1974, Pages: 269–273, D. Burke, V. S. Venturella and B. Z. Senkowski

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600630221

  12. Electron-capture GLC determination of phenylpropanolamine as a pentafluorophenyloxazolidine derivative

    Journal of Pharmaceutical Sciences

    Volume 65, Issue 5, May 1976, Pages: 740–742, L. Neelakantan and H. B. Kostenbauder

    Version of Record online : 18 SEP 2006, DOI: 10.1002/jps.2600650530

  13. Simultaneous GLC determination of phenylpropanolamine and chlorpheniramine in urine using a nitrogen selective detector

    Journal of Pharmaceutical Sciences

    Volume 67, Issue 1, January 1978, Pages: 118–119, H. Kinsun, M. A. Moulin and E. C. Savini

    Version of Record online : 21 SEP 2006, DOI: 10.1002/jps.2600670132

  14. The Pharmacokinetics and Bioavailability of Clemastine and Phenylpropanolamine in Single-Component and Combination Formulations

    The Journal of Clinical Pharmacology

    Volume 36, Issue 10, October 1996, Pages: 911–922, Horst F. Schran, Lew Petryk, Cheng-Tao Chang, Robert O'Connor and Mark B. Gelbert

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1996.tb04758.x

  15. Individual variability in the blood pressure response to intravenous phenylpropanolamine: A pharmacokinetic and pharmacodynamic investigation

    Clinical Pharmacology & Therapeutics

    Volume 45, Issue 3, March 1989, Pages: 252–259, Mary Beth O'Connell, Paul R Pentel and Cheryl L Zimmerman

    Version of Record online : 28 MAR 1989, DOI: 10.1038/clpt.1989.25

  16. High-pressure liquid chromatographic analysis of phenylpropanolamine in human plasma following derivatization with O-phthalaldehyde

    Journal of Pharmaceutical Sciences

    Volume 70, Issue 6, June 1981, Pages: 707–709, William D. Mason and Edwin N. Amick

    Version of Record online : 16 SEP 2006, DOI: 10.1002/jps.2600700640

  17. Evaluation of the Potential for Pharmacodynamic and Pharmacokinetic Drug Interactions Between Selegiline Transdermal System and Two Sympathomimetic Agents (Pseudoephedrine and Phenylpropanolamine) in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 8, August 2007, Pages: 978–990, Dr. Albert J. Azzaro, Dr. Chad M. VanDenBerg, Dr. John Ziemniak, Ms Eva M. Kemper, Dr. Lawrence F. Blob and Dr. Bryan J. Campbell

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007302950

  18. Interaction between phenylpropanolamine and monoamine oxidase inhibitors

    Journal of Pharmacy and Pharmacology

    Volume 21, Issue 9, September 1969, Pages: 577–580, A. D'MELLO

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1969.tb08322.x

  19. The effect of phenylpropanolamine on ambulatory blood pressure

    Clinical Pharmacology & Therapeutics

    Volume 40, Issue 2, August 1986, Pages: 144–147, Robert P Goodman, Jackson T Wright Jr, Cornelius O Barlascini, James M McKenney and Carolyn M Lambert

    Version of Record online : 18 AUG 1986, DOI: 10.1038/clpt.1986.153

  20. The Effect of Single-Dose Phenylpropanolamine on Blood Pressure in Patients with Hypertension Controlled by β Blockers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 10, Issue 2, March-April 1990, Pages: 85–91, Drs. Mary Beth O'Connell and Dr. Cynthia R. Gross

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1990.tb02554.x